Leucine-Rich, Glioma Inactivated 1 抗体
(Leucine-Rich, Glioma Inactivated 1 (LGI1))
This gene is rearranged as a result of translocations in glioblastoma cell lines. The protein contains a hydrophobic segment representing a putative transmembrane domain with the amino terminus located outside the cell. It also contains leucine-rich repeats with conserved cysteine-rich flanking sequences. This gene is predominantly expressed in neural tissues and its expression is reduced in low grade brain tumors and significantly reduced or absent in malignant gliomas. Mutations in this gene result in autosomal dominant lateral temporal epilepsy. [provided by RefSeq, Jul 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| Recombinant LGI1 抗体 | 人 | 兔 Monoclonal |
|
|
|
| LGI1 抗体 (AA 451-557) | 人 | 兔 Polyclonal |
|
|
|
| LGI1 抗体 (AA 37-113) (Atto 488) | 小鼠 | 小鼠 Monoclonal |
|
|
|
| LGI1 抗体 (AA 37-113) (Biotin) | 小鼠 | 小鼠 Monoclonal |
|
|
|
| LGI1 抗体 (AA 37-113) (FITC) | 小鼠 | 小鼠 Monoclonal |
|
|
|
| LGI1 抗体 (AA 37-113) (APC) | 小鼠 | 小鼠 Monoclonal |
|
|
|
| LGI1 抗体 (AA 37-113) (Atto 390) | 小鼠 | 小鼠 Monoclonal |
|
|
|
| LGI1 抗体 (AA 37-113) (Atto 594) | 小鼠 | 小鼠 Monoclonal |
|
|
|
| LGI1 抗体 (AA 37-113) (PerCP) | 小鼠 | 小鼠 Monoclonal |
|
|
|
| LGI1 抗体 (AA 37-113) (PE) | 小鼠 | 小鼠 Monoclonal |
|
|
|
| LGI1 抗体 (AA 37-113) (HRP) | 小鼠 | 小鼠 Monoclonal |
|
|
|
| LGI1 抗体 (AA 37-113) | 小鼠 | 小鼠 Monoclonal |
|
|
|
| LGI1 抗体 (N-Term) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| LGI1 抗体 (AA 25-74) | 人, 小鼠, 大鼠, Cow, 犬, 豚鼠, 马, 兔, Bat, 猴, Pig | 兔 Polyclonal |
|
|
|
| LGI1 抗体 | 人 | 兔 Monoclonal |
|
|
|
| LGI1 抗体 (AA 301-557) | 人 | 兔 Polyclonal |
|
|
|
| LGI1 抗体 (AA 35-285) | 人 | 兔 Polyclonal |
|
|
|
| LGI1 抗体 | 人 | 兔 Polyclonal |
|
|
|
| LGI1 抗体 (AA 1-557) | 人 | 小鼠 Polyclonal |
|
|
|
| LGI1 抗体 (AA 37-113) | 小鼠 | 小鼠 Monoclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 质量等级
- KD Validated
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- 24GB5950
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 451-557
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ICC (Immunocytochemistry: 有验证图片)
- IF/ICC (Immunofluorescence (fixed cells): 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 小鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- S283-7
- 标记
- Atto 488
- 抗体亚型
- IgG2a
- 抗原表位
- AA 37-113
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ICC (Immunocytochemistry: 有验证图片)
- IF/ICC (Immunofluorescence (fixed cells): 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 小鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- S283-7
- 标记
- Biotin
- 抗体亚型
- IgG2a
- 抗原表位
- AA 37-113
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ICC (Immunocytochemistry: 有验证图片)
- IF/ICC (Immunofluorescence (fixed cells): 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 小鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- S283-7
- 标记
- FITC
- 抗体亚型
- IgG2a
- 抗原表位
- AA 37-113
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ICC (Immunocytochemistry: 有验证图片)
- IF/ICC (Immunofluorescence (fixed cells): 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 小鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- S283-7
- 标记
- APC
- 抗体亚型
- IgG2a
- 抗原表位
- AA 37-113
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ICC (Immunocytochemistry: 有验证图片)
- IF/ICC (Immunofluorescence (fixed cells): 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 小鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- S283-7
- 标记
- Atto 390
- 抗体亚型
- IgG2a
- 抗原表位
- AA 37-113
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ICC (Immunocytochemistry: 有验证图片)
- IF/ICC (Immunofluorescence (fixed cells): 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 小鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- S283-7
- 标记
- Atto 594
- 抗体亚型
- IgG2a
- 抗原表位
- AA 37-113
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ICC (Immunocytochemistry: 有验证图片)
- IF/ICC (Immunofluorescence (fixed cells): 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 小鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- S283-7
- 标记
- PerCP
- 抗体亚型
- IgG2a
- 抗原表位
- AA 37-113
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ICC (Immunocytochemistry: 有验证图片)
- IF/ICC (Immunofluorescence (fixed cells): 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 小鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- S283-7
- 标记
- PE
- 抗体亚型
- IgG2a
- 抗原表位
- AA 37-113
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ICC (Immunocytochemistry: 有验证图片)
- IF/ICC (Immunofluorescence (fixed cells): 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 小鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- S283-7
- 标记
- HRP
- 抗体亚型
- IgG2a
- 抗原表位
- AA 37-113
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ICC (Immunocytochemistry: 有验证图片)
- IF/ICC (Immunofluorescence (fixed cells): 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 小鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- S283-7
- 标记
- unconjugated
- 抗体亚型
- IgG2a
- 抗原表位
- AA 37-113
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF/ICC (Immunofluorescence (fixed cells): 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 301-557
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 35-285
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-557
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
KO 验证
- 质量等级
- KO Validated
- 适用
- 小鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- N283-7
- 标记
- unconjugated
- 抗体亚型
- IgG2a
- 抗原表位
- AA 37-113
Latest Publications for our Leucine-Rich, Glioma Inactivated 1 抗体
: "CPA6, FMO2, LGI1, SIAT1 and TNC are differentially expressed in early- and late-stage oral squamous cell carcinoma--a pilot study." in: Oral oncology, Vol. 44, Issue 10, pp. 941-8, (2008) (PubMed).
: "Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission." in: Science (New York, N.Y.), Vol. 313, Issue 5794, pp. 1792-5, (2006) (PubMed).
: "Using gene-history and expression analyses to assess the involvement of LGI genes in human disorders." in: Molecular biology and evolution, Vol. 22, Issue 11, pp. 2209-16, (2005) (PubMed).
: "A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors." in: Oncogene, Vol. 17, Issue 22, pp. 2873-81, (1999) (PubMed).
: "Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission." in: Science (New York, N.Y.), Vol. 313, Issue 5794, pp. 1792-5, (2006) (PubMed).
: "Using gene-history and expression analyses to assess the involvement of LGI genes in human disorders." in: Molecular biology and evolution, Vol. 22, Issue 11, pp. 2209-16, (2005) (PubMed).
: "A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors." in: Oncogene, Vol. 17, Issue 22, pp. 2873-81, (1999) (PubMed).
Aliases for Leucine-Rich, Glioma Inactivated 1 抗体
leucine rich glioma inactivated 1 (LGI1) 抗体leucine-rich repeat LGI family, member 1 (Lgi1) 抗体
leucine-rich, glioma inactivated 1 (Lgi1) 抗体
leucine-rich, glioma inactivated 1 (LGI1) 抗体
leucine-rich, glioma inactivated 1 (lgi1) 抗体
leucine rich glioma inactivated 1 (Lgi1) 抗体
leucine-rich, glioma inactivated 1b (lgi1b) 抗体
leucine-rich, glioma inactivated 1a (lgi1a) 抗体
ADLTE 抗体
ADPAEF 抗体
ADPEAF 抗体
BB130740 抗体
EPITEMPIN 抗体
EPT 抗体
ETL1 抗体
fb78h12 抗体
IB1099 抗体
LGIa 抗体
MGC146600 抗体
wu:fb78h12 抗体
zgc:65886 抗体
您还需要查找其他产品吗？
- Leucine-Rich Repeat, Immunoglobulin-Like and Transmembrane Domains 1 抗体
- Leucine Rich Transmembrane and 0-Methyltransferase Domain Containing 抗体
- Leucine Rich Repeat and Coiled-Coil Domain Containing 1 抗体
- LETMD1 抗体
- LETM2 抗体
- LETM1 抗体
- Leptin Receptor 抗体
- Leptin 抗体
- LEPROTL1 抗体
- LEPROT 抗体
- LEPREL2 抗体
- LEPREL1 抗体
- Leprecan-Like 4 抗体
- LEPRE1 抗体
- LEO1 抗体
- Leng1 抗体
- LEMD3 抗体
- LEMD2 抗体
- LELP1 抗体
- Leishmanolysin-Like (Metallopeptidase M8 Family) 抗体
You are here:
